CA2580035A1 - Diversion device to increase cerebral blood flow - Google Patents

Diversion device to increase cerebral blood flow Download PDF

Info

Publication number
CA2580035A1
CA2580035A1 CA002580035A CA2580035A CA2580035A1 CA 2580035 A1 CA2580035 A1 CA 2580035A1 CA 002580035 A CA002580035 A CA 002580035A CA 2580035 A CA2580035 A CA 2580035A CA 2580035 A1 CA2580035 A1 CA 2580035A1
Authority
CA
Canada
Prior art keywords
membrane
frame
blood flow
aorta
aortic occlusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002580035A
Other languages
French (fr)
Inventor
Daniel Vancamp
Eric D. Nielson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2580035A1 publication Critical patent/CA2580035A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136—Balloons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027—Type of occlusion
    • A61B17/12036—Type of occlusion partial occlusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00579—Barbed implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592—Elastic or resilient implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00597—Implements comprising a membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other

Abstract

Methods and devices provide for temporary partial aortic occlusion to achieve diversion of blood flow to the brain in patients suffering from cerebral ischemia. The device can include an expandable frame with a membrane mounted on a first portion of the frame. The membrane can have at least one opening. In some embodiments, the membrane has an outer region and an inner region, and an opening in the inner region. In use, the frame can expand to conform to the inner walls of the aorta and the membrane can at least partially occlude the aorta thereby increasing cerebral perfusion. The frame can include one or more anchors to aid in maintaining the device in position against the arterial blood flow pressure.

Description

DIVERSION DEVICE TO INCREASE CEREBRAL BLOOD FLOW
FIELD OF THE INVENTION

The present invention relates generally to devices and methods for providing temporary partial obstruction of aortic blood flow, with a resulting increase in cerebral blood flow. More particularly, the invention provides a device with a membrane for partially occluding an artery.

BACKGROUND
Stroke is a disruption of blood to a portion of the brain. The two main mechanisms are occlusion of a blood vessel (ischemic stroke) or hemorrhage of a blood vessel (hemorrhagic stroke). Ischemic stroke is significantly more common.
Current state of the art treatment for ischemic stroke includes the injection of tissue plasminogen activator (tPA) within four hours of the event. Some evidence also points to a benefit from tPA out to 12 hours. Alternate therapies include mechanical dislocation or retrieval of the clot. These treatments are effective because the brain has significant collateral blood flow. Thus, when the primary blood supply to an area is disrupted, collateral flow provides some amount of oxygen to the affected tissue.
The quantity is dependent on the size of the vessel obstructed, the location of the obstruction, blood oxygen level, and cerebral blood flow volume. The model for this situation is an area of dead tissue (infarction) that is dead and unrecoverable.
Surrounding this tissue is the penumbra; a zone of oxygen depleted tissue.
This tissue ranges from dying tissue through tissue experiencing insignificant oxygen level drops.
Clearly within this continuum there exists tissue that is not dead but is not functioning due to oxygen deficit. Stroke intervention is thus intended to recover as much of the penumbra as possible, limiting the amount of tissue killed in the brain.
One solution to increasing the effectiveness of treatment is to increase the amount of oxygen delivered via collateral blood flow. Unlike some parts of the body, increasing blood pressure does not generally increase flow to the brain. A
solution proposed in US Patent No. 6,743,196, to Barbut et al., is to insert a balloon into the aorta to partially occlude the aorta above the renal arteries as a means of increasing cerebral blood flow. Limitations of this device and method include mechanical complexity, constant monitoring requirements, and maintaining arterial access for the length of its use. Additionally, an inherent drawback with using a balloon to occlude a vessel is that balloons are always susceptible to failure (e.g., popping, leaking).
A device that is to be placed in an artery must address additional concerns compared to devices placed in veins because of the hemodynamic differences between arteries and veins. Arteries are much more flexible and elastic than veins and, in the arteries, blood flow is pulsatile with large pressure variations between systolic and diastolic flow. These pressure variations cause the artery walls to expand and contract. Blood flow rates in the arteries vary from about I L/min to about 5 L/min.
A need exists for a less complex, easily delivered, temporary arterial occlusion device that partially occludes an artery to increase cerebral blood flow, while avoiding the drawbacks of the prior devices. An associated filter that captures embolic material would be advantageous as well.

SUMMARY OF THE INVENTION
The present invention provides devices and methods for temporarily increasing cerebral blood flow. More specifically, a vascular occlusion, obstruction and/or constriction device is disclosed. The terms occlusion, obstruction, and constriction are used interchangeably herein to refer to partial or complete blockage of a vessel, and to any of the devices that provide such blockage. The devices include an occluding, obstructing, or constricting mechanism. In some embodiments, the devices include a filtration mechanism to trap emboli. The devices are collapsible and expandable to facilitate insertion into and removal from the vessel.
In one embodiment, the device includes an expandable frame with a membrane mounted on a first portion of the frame. The membrane has at least one opening. In some embodiments, the membrane has an outer region and an inner region, and an opening in the inner region. In use, the frame expands to conform to the inner walls of the aorta and the membrane at least partially occludes the aorta thereby increasing cerebral perfusion. The frame can include one or more anchors to aid in maintaining the device in position against the arterial blood flow pressure.
In another embodiment, the membrane is biodegradable such that upon insertion of the device, the membrane provides partial occlusion of the aorta to increase cerebral blood flow. As the membrane biodegrades, cerebral blood flow gradually returns to a normal state. The frame of the device can then be removed.
In a further embodiment, the expandable frame is a mesh tube with a membrane extending across at least part of a first end of the tube. In some embodiments, the second end of the tube is covered by a mesh or other filtering means.
In use, the expandable filter device is inserted into the aorta and expanded such that the membrane extends across the aorta to partially occlude the aorta and increase cerebral blood flow. In some embodiments, the membrane is at least partially permeable to blood. In other embodiments, the membrane has an opening to allow a limited amount of blood flow through the device. In one embodiment, the opening is sized to receive a catheter, and the downstream end of the device has one or more openings sized to receive a catheter. A catheter can traverse the filter device to provide access to arteries and organs upstream of the filter device.

BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows an embodiment of a filter device according to the present invention.
FIGS. 2-4 show additional embodiments of filter devices according to the present invention.
FIG. 5 shows a filter device according to the present invention in place in a vessel.

DETAILED DESCRIPTION
The filter devices disclosed herein are characterized by their ability to withstand high arterial blood flow rates for an extended time and their ability to expand and contract with the wall of the aorta. In some embodiments, the devices are made of a material that is impermeable to blood such as Teflon or nitinol. The devices can have an anti-thrombogenic coating, such as heparin or Carmeda BioActive Surface (Carmeda Inc., US). In other embodiments, the devices are made of a material that is permeable to blood, such as a mesh, woven material, or a thin polymer. All or a part of the device can be made of a biodegradable material.
The device is collapsible and expandable and can be delivered surgically, endoscopically, or percutaneously with cannulas or intravascular catheters. In one embodiment, the device is introduced through the femoral artery. In another embodiment, the device is introduced through the brachial artery.
The device can be left in the aorta permanently or the device can be removed after temporary placement. In addition to or instead of a friction fit of an expandable frame, the device can include one or more anchoring mechanisms, such as sutures, surgical clips, hooks, loops, spikes, pins, or adhesives. The device can be of any shape, such as conical, frustoconical, ogival, cylindrical, hemispherical, or modifications of such shapes. The device can be self-expanding or is can be expanded mechanically such as by a balloon. Self-expanding devices can be made of a shape memory metal such as nitinol. In one embodiment, the device is flexible and expandable to fit a variety of vessel sizes. In another embodiment, the device is sized for a specific vessel. Multiple devices of varying sizes can be packaged together.
The method of the invention involves the temporary partial occlusion of arterial blood flow and resulting diversion of blood flow to the brain. The device of the invention is inserted into the aorta at or below the aortic arch and above the femoral arteries. In one embodiment, the device is placed in the aorta in the region of the renal arteries. In another embodiment, the device is placed in the aortic arch below the common carotid artery and braciocephalic trunk. In a further embodiment, the device is placed in the celiac trunk. In a still further embodiment, the device can be placed in the vena cava.
A membrane covering at least part of a first portion of the device serves to partially occlude the vessel. In some embodiments, the membrane is at least partially permeable to blood. The level of permeability and/or surface area that is permeable to blood can be adjusted to vary the amount of occlusion and thus vary the amount of blood flow diverted to the brain. In other embodiments, the membrane has one or more openings. In these embodiments, the membrane may or may not be partially permeable to blood. The number and size of the openings can be varied to determine the amount of blood flow diverted to the brain.
In a first embodiment, a filter device for temporary partial occlusion of an artery is provided as shown in FIG. 1. The device 10 includes a frame 20 having a first portion 12 and a second portion 14, and a membrane 30 disposed over the first portion 12. The membrane 30 is attached to the frame 20 by any suitable means including sonic or laser welding or adhesive bonding. In some embodiments, the membrane 30 is at least partially permeable to blood. The membrane 30 can be biodegradable. In some embodiments, the biodegradable material is selected to degrade over a desired time range from a very short time to a very long time after the device is inserted. In one embodiment, the membrane 30 is made of polyglycolide.
In another embodiment, the membrane 30 is a thin membrane with one or more laser-cut holes to allow blood flow. The thin membrane can be made of poly(dioxanone).
In the embodiment shown in FIG. 1, the membrane 30 has a single opening 40 substantially centrally located. Alternatively, the opening 40 can be located off-center, or the membrane can have multiple openings. The number, size and position of openings 40 in the membrane 30 are selected to achieve a desired amount of blood flow diversion to the brain.
In some embodiments, the frame 20 includes multiple support members, such as struts 50. The struts 50 can be compressible, expandable, or flexible. The frame 20 is at least partially expandable to conform to the lumen of a vessel. In one embodiment, the frame 20 is made of a super elastic material such as nitinol.
In other embodiments, the frame 20 is made of titanium, Teflon, stainless steel, ceramic, polymers, or mixtures of such materials. In still further embodiments, the frame 20 is made of a mesh or woven material. In some embodiments, the second, or downstream, portion of the frame 20 forms a filter to capture emboli and/or fragments of the biodegradable membrane.
In another embodiment, shown in FIG. 3, the frame 220 is a mesh tube 270.
In a still further embodiment, shown in FIG. 4, the frame 320 is solid. In embodiments with an open frame structure, such as those shown in FIGS. 1-3, the frame 20 can be covered with a permeable materia1400, such as a mesh, netting, or membrane to provide an additional filtration mechanism. In some embodiments, a permeable materia1400 covering the frame 20 provides an additional mechanism to increase the occlusion of the artery and increase the blood flow to the brain.
In devices having a tapered, angled, or cone shape, such as those shown in FIGS. 4, 2, and 4, at least the first end 12, 112, 312, is expandable. In one embodiment, shown in FIG. 2, the frame 120 includes a flexible or expandable band or ring 190 on the first portion 112. The flexible ring 190 can aid in attaching the membrane 130 to the frame 120. In another embodiment, the flexible ring 190 is attached to the frame 120 and the membrane 130 is attached to the ring 190.

One or more anchors 160 can be included to aid in securing the device in the vessel. The anchors 160 can be hooks, spikes, loops, pins or any other protrusion sufficient to secure the device in the vessel. In one embodiment, the anchors 160 are mechanically retractable. In another embodiment, the anchors 160 are made of a deformable, flexible, or super elastic material, and are removable from a vessel wall by compressing or folding the frame 20. The anchors 160 can be attached to the frame 20, struts 50, ring 190, or permeable material 400.
FIG. 5 shows a partial occlusion device 510 in place in the aorta. The device 510 includes a frame 520 made up of struts 550. A first portion 512 of the frame 520 is covered by a membrane 530 with a central opening 540. Anchors 560 extend from the first portion 512 of the frame 520 into the vessel walls 500 to secure the device 510 against blood flow, which is indicated by the arrow.
A mixture of carbon dioxide and oxygen (CO2/02) can be administered to the patient before, during, or after insertion of the filter device to provide additional blood flow to the brain. Enriching the blood content of COz while maintaining a high oxygen level causes blood to be shunted to the brain.
Although the foregoing invention has, for the purposes of clarity and understanding, been described in some detail by way of illustration and example, it will be obvious that certain changes and modifications may be practiced with will still fall within the scope of the appended claims. Moreover, it will be understood that each and every feature described for any given embodiment or in any reference incorporated herein, can be combined with any of the other embodiments described herein.

Claims (9)

1. A partial aortic occlusion device comprising:
an expandable frame having a first portion and a second portion;
a membrane mounted on the first portion of the frame, the membrane having an outer region and an inner region, the membrane having an opening in the inner region, wherein the membrane is biodegradable;
wherein during use, the expandable frame expands to conform to the aorta and the membrane at least partially occludes the aorta thereby increasing cerebral perfusion.
2. The partial aortic occlusion device of claim 1, wherein the frame includes one or more anchors configured to removably attach the device to a wall of the aorta.
3. The partial aortic occlusion device of claim 1, wherein the expandable frame is made of super elastic material.
4. The partial aortic occlusion device of claim 1, wherein the expandable frame includes at least two struts, the struts spaced apart in the first portion of the frame and connected in the second portion of the frame.
5. The partial aortic occlusion device of claim 4, wherein at least two struts include one or more anchors configured to removably attach the device to a wall of the aorta.
6. The partial aortic occlusion device of claim 1, wherein the expandable frame is a mesh tube.
7. The partial aortic occlusion device of claim 1, wherein the frame has at least one opening in the second portion, and the opening in the second portion and the opening in the membrane are sized to receive a catheter.
8. The partial aortic occlusion device of claim 1, wherein the membrane is at least partially permeable to blood.
9. The partial aortic occlusion device of claim 1, wherein the membrane has two or more openings.
CA002580035A 2004-09-10 2005-09-08 Diversion device to increase cerebral blood flow Abandoned CA2580035A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/937,916 US7927346B2 (en) 2004-09-10 2004-09-10 Diversion device to increase cerebral blood flow
US10/937,916 2004-09-10
PCT/US2005/032030 WO2006031602A1 (en) 2004-09-10 2005-09-08 Diversion device to increase cerebral blood flow

Publications (1)

Publication Number Publication Date
CA2580035A1 true CA2580035A1 (en) 2006-03-23

Family

ID=35520913

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002580035A Abandoned CA2580035A1 (en) 2004-09-10 2005-09-08 Diversion device to increase cerebral blood flow

Country Status (7)

Country Link
US (1) US7927346B2 (en)
EP (1) EP1788957B1 (en)
AT (1) ATE388669T1 (en)
CA (1) CA2580035A1 (en)
DE (1) DE602005005347T2 (en)
ES (1) ES2304723T3 (en)
WO (1) WO2006031602A1 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
EP1648340B1 (en) * 2003-05-19 2010-03-03 SeptRx, Inc. Tissue distention device and related methods for therapeutic intervention
US20060079927A1 (en) * 2004-10-08 2006-04-13 Medtronic Vascular, Inc., A Delaware Corporation Detachable joint catheter and method
US20070293808A1 (en) * 2006-04-27 2007-12-20 Williams Michael S Renal blood flow augmentation for congestive heart failure treatment
US20100179583A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of deploying and retrieving an embolic diversion device
US9480548B2 (en) * 2006-09-11 2016-11-01 Edwards Lifesciences Ag Embolic protection device and method of use
US9339367B2 (en) 2006-09-11 2016-05-17 Edwards Lifesciences Ag Embolic deflection device
US20100179647A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure
US8460335B2 (en) * 2006-09-11 2013-06-11 Embrella Cardiovascular, Inc. Method of deflecting emboli from the cerebral circulation
US20080161825A1 (en) * 2006-11-20 2008-07-03 Stout Medical Group, L.P. Anatomical measurement tool
DE102006056283A1 (en) * 2006-11-29 2008-06-05 Biomagnetik Park Gmbh Occlusion device for closing left heart auricle of patient, has cladding bag provided with fillable opening at its proximal end and partially made of thermoplastic polyurethane, where bag is partially filled with non-degradable plastic
US9017362B2 (en) * 2007-06-13 2015-04-28 Cook Medical Technologies Llc Occluding device
WO2009003049A2 (en) 2007-06-25 2008-12-31 Micro Vention, Inc. Self-expanding prosthesis
US8105261B2 (en) * 2007-07-02 2012-01-31 Cardiac Pacemakers, Inc. Osmotic devices and methods for diuretic therapy
US9198687B2 (en) * 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US8066757B2 (en) * 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US20100256600A1 (en) * 2009-04-04 2010-10-07 Ferrera David A Neurovascular otw pta balloon catheter and delivery system
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US8926680B2 (en) * 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US20100174309A1 (en) * 2008-05-19 2010-07-08 Mindframe, Inc. Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US20090192455A1 (en) * 2008-01-07 2009-07-30 David Ferrera Novel enhanced ptna rapid exchange type of catheter system
KR101819554B1 (en) 2008-02-22 2018-01-17 마이크로 테라퓨틱스 인코포레이티드 Methods and apparatus for flow restoration
CN101977650A (en) 2008-04-11 2011-02-16 曼德弗雷姆公司 Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
WO2012002944A1 (en) 2010-06-29 2012-01-05 Artventive Medical Group, Inc. Reducing flow through a tubular structure
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9744033B2 (en) 2011-04-01 2017-08-29 W.L. Gore & Associates, Inc. Elastomeric leaflet for prosthetic heart valves
US10117765B2 (en) 2011-06-14 2018-11-06 W.L. Gore Associates, Inc Apposition fiber for use in endoluminal deployment of expandable implants
US9554806B2 (en) 2011-09-16 2017-01-31 W. L. Gore & Associates, Inc. Occlusive devices
US9782282B2 (en) 2011-11-14 2017-10-10 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9877858B2 (en) 2011-11-14 2018-01-30 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9375308B2 (en) 2012-03-13 2016-06-28 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US20130273180A1 (en) 2012-04-16 2013-10-17 Denise Barbut System and method for improving outcome of cerebral ischemia
DK2863813T3 (en) * 2012-06-26 2018-10-01 Vvt Medical Ltd BIODEGRADABLE BLOOD CARDOUSCLUSION AND SUMMARY
WO2014002087A1 (en) 2012-06-26 2014-01-03 V.V.T. Med Ltd. Vessel occlusion devices, kits and methods
GB2510151B (en) 2013-01-25 2015-07-22 Cook Medical Technologies Llc Vascular plug
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US11911258B2 (en) 2013-06-26 2024-02-27 W. L. Gore & Associates, Inc. Space filling devices
US10004512B2 (en) * 2014-01-29 2018-06-26 Cook Biotech Incorporated Occlusion device and method of use thereof
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
EP3142598B1 (en) 2014-05-16 2020-07-08 Veosource SA Implantable self-cleaning blood filters
CH710439A1 (en) * 2014-12-18 2016-06-30 Intellistent Ag Adjustable multi-lumen stent.
US10279094B2 (en) 2015-01-21 2019-05-07 United States Of America As Represented By The Secretary Of The Air Force Endovascular variable aortic control catheter
CN104771200B (en) * 2015-04-15 2017-05-24 中国人民解放军第二军医大学 Intracranial aneurysm neck reconstruction device
CN114652385A (en) 2015-05-14 2022-06-24 W.L.戈尔及同仁股份有限公司 Device for occluding an atrial appendage
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
WO2017200866A1 (en) * 2016-05-17 2017-11-23 The Cleveland Clinic Foundation Apparatus for blocking bloodflow through a dissected aorta
JP7177061B2 (en) 2016-09-01 2022-11-22 マイクロベンション インコーポレイテッド Temporary aortic isolation device
US11389169B2 (en) 2016-09-01 2022-07-19 Microvention, Inc. Temporary aortic occlusion device
US10646227B2 (en) 2016-12-29 2020-05-12 Cerepeutics, LLC Systems and methods for acute treatment to limit intracerebral hemorrhage growth
WO2018132623A1 (en) 2017-01-12 2018-07-19 The Regents Of The University Of California Endovascular perfusion augmentation for critical care
EP3459469A1 (en) 2017-09-23 2019-03-27 Universität Zürich Medical occluder device
US11173023B2 (en) 2017-10-16 2021-11-16 W. L. Gore & Associates, Inc. Medical devices and anchors therefor
JP2022549717A (en) 2019-09-26 2022-11-28 ウニベルシタット チューリッヒ left atrial appendage closure device
US20210322026A1 (en) 2020-03-16 2021-10-21 Certus Critical Care, Inc. Blood flow control devices, systems, and methods and error detection thereof
US11376028B1 (en) 2021-04-17 2022-07-05 Inquis Medical, Inc. Devices, systems, and methods for removing obstructive material from body lumens
WO2023278495A2 (en) 2021-06-28 2023-01-05 Inquis Medical, Inc. Apparatuses and methods for controlling removal of obstructive material

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2567405B1 (en) 1984-07-12 1988-08-12 Lefebvre Jean Marie MEDICAL FILTER
US4601706A (en) * 1984-12-03 1986-07-22 Rene Aillon Central venous pressure catheter for preventing air embolism and method of making
FR2632848A1 (en) * 1988-06-21 1989-12-22 Lefebvre Jean Marie FILTER FOR MEDICAL USE
FR2660189B1 (en) * 1990-03-28 1992-07-31 Lefebvre Jean Marie DEVICE INTENDED TO BE IMPLANTED IN A VESSEL WITH SIDE LEGS WITH ANTAGONIST TEETH.
US5308320A (en) * 1990-12-28 1994-05-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method
US5584803A (en) * 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5458574A (en) * 1994-03-16 1995-10-17 Heartport, Inc. System for performing a cardiac procedure
FR2689388B1 (en) * 1992-04-07 1999-07-16 Celsa Lg PERFECTIONALLY RESORBABLE BLOOD FILTER.
FR2696092B1 (en) * 1992-09-28 1994-12-30 Lefebvre Jean Marie Kit for medical use composed of a filter and its device for placement in the vessel.
US5330451A (en) * 1992-12-17 1994-07-19 Shelhigh, Inc. Multi purpose perfusion cannula
FR2714814B1 (en) * 1994-01-10 1996-03-29 Bentex Trading Sa Device intended to be placed in a vessel with flattened fixing lugs.
US5437633A (en) * 1994-03-30 1995-08-01 The University Of North Carolina At Chapel Hill Selective aortic arch perfusion
AU2255195A (en) * 1994-04-06 1995-10-30 William Cook Europe A/S A medical article for implantation into the vascular system of a patient
US5478309A (en) * 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
WO1997042879A1 (en) * 1996-05-14 1997-11-20 Embol-X, Inc. Aortic occluder with associated filter and methods of use during cardiac surgery
US5662671A (en) * 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US6258120B1 (en) * 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
US6361545B1 (en) * 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
HU222543B1 (en) * 1998-02-23 2003-08-28 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US7004962B2 (en) * 1998-07-27 2006-02-28 Schneider (Usa), Inc. Neuroaneurysm occlusion and delivery device and method of using same
US7128073B1 (en) * 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US6152144A (en) 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
IT1303757B1 (en) * 1998-11-16 2001-02-23 Sigma Tau Ind Farmaceuti INDUSTRIAL PROCESS FOR THE PRODUCTION OF L-CARNITINA.
US6231551B1 (en) * 1999-03-01 2001-05-15 Coaxia, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
US6743196B2 (en) * 1999-03-01 2004-06-01 Coaxia, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
US6368338B1 (en) * 1999-03-05 2002-04-09 Board Of Regents, The University Of Texas Occlusion method and apparatus
US6585756B1 (en) * 1999-05-14 2003-07-01 Ernst P. Strecker Implantable lumen prosthesis
US6142987A (en) * 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
US6352667B1 (en) * 1999-08-24 2002-03-05 Absorbable Polymer Technologies, Inc. Method of making biodegradable polymeric implants
US6652555B1 (en) * 1999-10-27 2003-11-25 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
US6361546B1 (en) * 2000-01-13 2002-03-26 Endotex Interventional Systems, Inc. Deployable recoverable vascular filter and methods for use
US6702773B1 (en) * 2000-02-01 2004-03-09 Cardeon Corporation Methods and devices for performing differential perfusion
US6595980B1 (en) * 2001-02-23 2003-07-22 Coaxia, Inc. Devices and methods for preventing distal embolization using flow reversal by occlusion of the brachiocephalic artery
US8070769B2 (en) * 2002-05-06 2011-12-06 Boston Scientific Scimed, Inc. Inverted embolic protection filter
US7303575B2 (en) * 2002-08-01 2007-12-04 Lumen Biomedical, Inc. Embolism protection devices
SE0301974D0 (en) * 2003-07-03 2003-07-03 Astra Tech Ab A device for promoting regeneration of an injured nerve, a kit and a biodegradable sheet for preparing such a device
DE602004009598T2 (en) * 2003-09-12 2008-07-24 NMT Medical, Inc., Boston DEVICE FOR PREVENTING THE FORMATION OF THROMBAS IN THE LEFT PORTFOLIO
WO2005102221A1 (en) * 2004-03-31 2005-11-03 Cook Incorporated Multi-portion endoluminal prosthesis

Also Published As

Publication number Publication date
US7927346B2 (en) 2011-04-19
DE602005005347D1 (en) 2008-04-24
WO2006031602A1 (en) 2006-03-23
DE602005005347T2 (en) 2009-03-12
EP1788957B1 (en) 2008-03-12
ES2304723T3 (en) 2008-10-16
EP1788957A1 (en) 2007-05-30
US20060058833A1 (en) 2006-03-16
ATE388669T1 (en) 2008-03-15

Similar Documents

Publication Publication Date Title
EP1788957B1 (en) Diversion device to increase cerebral blood flow
US11751987B2 (en) Embolic protection device
AU745809B2 (en) Implantable cerebral protection device and methods of use
US6585756B1 (en) Implantable lumen prosthesis
DE60017928T2 (en) COVERING DEVICE FOR THE OSTIUM OF THE LEFT FORWARD ANNEX
CA2254831C (en) Aortic occluder with associated filter and methods of use during cardiac surgery
EP2021064B1 (en) Vascular filter
US8568465B2 (en) Device for rechanneling a cavity, organ path or vessel
US6361545B1 (en) Perfusion filter catheter
WO1997042879A9 (en) Aortic occluder with associated filter and methods of use during cardiac surgery
JP2019516459A (en) Filter and occluder system and related methods and devices

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued